Puma Biotechnology | Umlaufvermögen

Current Assets Veränderung Datum
Agios Pharmaceuticals USD 833.83M 129.48M 2023-12
Alnylam Pharmaceuticals USD 2.98B 2.76M 2023-12
Amgen USD 30.33B 18.14B 2023-12
Daiichi Sankyo JPY 1.52T 15.17B 2023-09
Exelixis USD 1.44B 147.16M 2023-09
Gilead Sciences USD 16.45B 474M 2023-12
Incyte USD 4.65B 242.74M 2023-12
Moderna USD 10.32B 474M 2023-12
Pfizer USD 74.01B 665M 2023-09
PTC Therapeutics USD 1.22B 678.27M 2023-12
Regeneron Pharmaceuticals USD 24.49B 5.85B 2023-12
Roche Holding CHF 30.98B 2.84B 2023-06
Sarepta Therapeutics USD 2.45B 21.76M 2023-09
Takeda JPY 2.46T 9.95B 2023-09
TG Therapeutics USD 319.11M 110.54M 2023-09
Ultragenyx Pharmaceutical USD 599.19M 102.95M 2023-09
Vertex Pharmaceuticals USD 14.7B 822.9M 2023-09



Puma Biotechnology Umlaufvermögen - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Apr 2024.